Patents by Inventor Jason D. Salter

Jason D. Salter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for Screening of Anti-Viral Compounds That Inhibit Specific Interaction Interfaces Between Cullin5 and an ElonginB/ElonginC/ CBF-beta/HIV-1 Vif Complex
    Publication number: 20150268247
    Abstract: The present invention relates to the production of an ElonginB/ElonginC/Vif/CBF? tetramer complex comprising full-length Vif protein. The present invention provides an assay for screening any agent that inhibits the ability of Vif to bind with Cul5. The invention provides an agent identified by the screening methods and methods of treatment using the identified agent. The invention also provides compositions that inhibit Vif-Cul5 binding based upon regions identified in Vif and Cul5 that mediate Vif-Cul5 binding.
    Type: Application
    Filed: October 22, 2013
    Publication date: September 24, 2015
    Inventors: Joseph E. Wedekind, Jason D. Salter, Geoffrey M. Lippa, Ivan A. Belashov
  • Solution Assay and High Through-Put Screen to Probe Interaction Between Human Cullin-Ring Ligase Complex and HIV-VIF Protein
    Publication number: 20120271036
    Abstract: The present invention relates to large-scale production of ElonginB, ElonginC, Vif, and Cullin5. The present invention provides an assay for screening any agent that inhibits the ability of Vif to bind with Cul5. The invention provides an agent identified by the screening methods and methods of treatment using the identified agent.
    Type: Application
    Filed: October 29, 2010
    Publication date: October 25, 2012
    Inventors: Harold C. Smith, Jason D. Salter, Joseph E. Wedekind